The 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) was held virtually this year and showcased the latest advances in the field of transplantation and cellular therapies.
VJHemOnc is joined by Christian Chabannon, MD, PhD, Institut Paoli Calmettes, Marseille, France, who chaired an insightful discussion on the main takeaways from the EBMT 2021 meeting, including trial updates in conditioning, novel approaches to managing graft-versus-host disease, the role of transplantation in rarer hematological malignancies and the latest news in immune effector cell therapies.
In this roundtable discussion, Prof. Chabannon is joined by Nico Gagelmann, MD, of the University Medical Center Hamburg-Eppendorf, Hamburg, Germany, Zinaida Perić, MD, PhD, of the University Hospital Centre Zagreb, School of Medicine, Zagreb, Croatia and Eolia Brissot, MD, of Saint-Antoine Hospital, Paris, France.
The post The Post-EBMT VJSessions from VJHemOnc appeared first on VJHemOnc.
